Using CRISPR-Cas9 genome editing technology, I will be creating a stable cell-line for the industrial production of Adeno-Associated Virus as a gene therapy vector.
MEng in Bioengineering and Biomedical Engineering, 2016-2017
McGill University (Montreal, Canada)
B.Sc. in Biology (minor in Environment), 2011-2014
McGill University (Montreal, Canada)